CHICAGO, March 31, 2023 (GLOBE NEWSWIRE) — The future of biomarkers looks promising. As new technologies and techniques emerge, the use of biomarkers will become more common. Expect more advanced biomarkers that can detect diseases earlier and more accurately in the next few years. The ability to accurately diagnose and monitor disease will be vastly improved, empowering healthcare professionals to better treat their patients. In addition, the development of personalized medicine and precision medicine will be significantly advanced through the use of biomarkers. This will allow doctors to tailor treatments to individual patients, leading to better outcomes. As the cost of biomarkers continues to decrease and their use becomes more widespread, the industry is expected to grow significantly.
biomarker market in terms of revenue, was estimated at US$59.1 billion in 2023 and is projected to reach US$104.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028, according to a recent by MarketsandMarkets™ published report. Factors responsible for the growth of the biomarkers market are mainly the high prevalence of cancer and heart problems and advances in biomarkers.
Download an illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43
biomarkers market Scope:
| report coverage | details |
| Market revenue in 2023 | $59.1 billion |
| Estimated value by 2028 | $104.0 billion |
| growth rate | Ready to grow at a CAGR of 12.0% |
| Market Size Available for | 2021-2028 |
| forecast period | 2023-2028 |
| Forecast Units | Value (Billion USD) |
| report coverage | Sales Forecast, Competitive Landscape, Growth Factors and Trends |
| Covered Segments | Product & Service, Type, Application, Disease Indication and Region |
| Regions Covered | North America, Europe, Asia Pacific and Rest of the World |
| report highlights | Updated player financial information / product portfolio |
| key market… |
[ad_2]
Source story
